Using fitness trackers to improve exercise before cancer surgery
Assessment, Monitoring and Optimisation of Prehabilitation Patients Using Wearable Fitness Trackers
NA · Imperial College London · NCT06071650
This study is testing if using fitness trackers and exercise support can help cancer patients get fitter before surgery and improve their recovery.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 82 (estimated) |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Sponsor | Imperial College London (other) |
| Drugs / interventions | chemotherapy |
| Locations | 2 sites (London and 1 other locations) |
| Trial ID | NCT06071650 on ClinicalTrials.gov |
What this trial studies
This study focuses on prehabilitation, which involves prescribed exercise before surgery to enhance patients' fitness and improve surgical outcomes. Participants will be assessed for their baseline fitness using a modified Rockport test and will exercise to reach a target heart rate, monitored through a wrist-worn fitness tracker. Weekly telephone calls will provide support and track progress. The aim is to determine if these methods are more effective than current practices in assessing fitness and exercise intensity for patients undergoing surgery for cancer.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18-80 with a new diagnosis of non-metastatic oesophago-gastric, hepatobiliary, or lung cancer who are eligible for surgical resection.
Not a fit: Patients with non-resectable disease or those who have declined surgery will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to improved fitness and better surgical outcomes for cancer patients.
How similar studies have performed: While prehabilitation is gaining recognition, there is limited existing evidence supporting the best practices, making this approach relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18 - 80 years. * New diagnosis of non-metastatic oesophago-gastric (OG), hepatobiliary (HPB) or Lung Cancer (LC) being offered surgical resection with curative intent at Imperial College NHS Healthcare Trust (OG/HPB) or Guy's and St Thomas' Hospital (LC). * Proficient in English * Enrolled in a prehabilitation programme. * Capable of providing informed consent and willing to comply with all parts of the protocol. Exclusion Criteria: * Unable to provide informed consent. * Non-resectable disease. * Declined surgery. * No access to smart phone/tablet or internet * Involved in other current research or have recently been involved in any research prior to recruitment
Where this trial is running
London and 1 other locations
- Guy's and St Thomas' NHS Foundation Trust — London, United Kingdom (RECRUITING)
- Imperial College Healthcare NHS Trust — London, United Kingdom (RECRUITING)
Study contacts
- Principal investigator: Krishna Moorthy — Imperial College London
- Study coordinator: Nigel JM Noor, MBChB
- Email: Nigel.Noor@nhs.net
- Phone: 07905000796
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Cancer, preoperative exercise, prehabilitation, activity tracker, kinesiotherapy